Evidence map›Paper›PMID 36708095›Full record

ArticleJournal of diabetes investigation2023

Association of acute-to-chronic glycemic ratio and outcomes in patients with COVID-19 and undiagnosed diabetes mellitus: A retrospective nationwide cohort study.

Masaki Uchihara, Takehiro Sugiyama, Ryotaro Bouchi, Nobuaki Matsunaga, Yusuke Asai, Hiroyuki Gatanaga, Mitsuru Ohsugi, Norio Ohmagari, Hiroshi Kajio, Kohjiro Ueki

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Masaki UchiharaDepartment of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Toyama, Tokyo, Japan.
Takehiro SugiyamaDiabetes and Metabolism Information Center, Research Institute, National Center for Global Health and Medicine, Toyama, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5391-682X
Ryotaro BouchiDepartment of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Toyama, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7664-4342
Nobuaki MatsunagaAMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yusuke AsaiAMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Hiroyuki GatanagaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Mitsuru OhsugiDepartment of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Toyama, Tokyo, Japan.
Norio OhmagariAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Hiroshi KajioDepartment of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Toyama, Tokyo, Japan.
Kohjiro UekiDepartment of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Toyama, Tokyo, Japan.
National Center for Global Health and Medicine · JPUniversity of Tsukuba · JP

Funding

National Center for Global Health and Medicine Gift Fund
6 · The paper itself

Abstract

AIMS/

introductionTo assess the association of undiagnosed diabetes mellitus and its acute-to-chronic glycemic ratio with clinical outcome in patients hospitalized with coronavirus disease 2019 (COVID-19) using a large-scale nationwide registry in Japan. MATERIALS AND

methodsOverall, 4,747 patients were included between July 2021 and January 2022. We evaluated blood glucose and glycated hemoglobin levels at admission, and calculated the acute-to-chronic glycemic ratio for each non-diabetes mellitus, undiagnosed diabetes mellitus and pre-existing diabetes mellitus group. The primary composite outcome comprised in-hospital mortality, invasive mechanical ventilation, extracorporeal membrane oxygenation support, intensive care unit admission and transfer to a more advanced medical facility.

resultsCompared with the non-diabetes mellitus group, the undiagnosed diabetes mellitus group was significantly associated with a worse COVID-19 outcome (odds ratio 2.18, 95% confidence interval 1.50-3.18). In patients with undiagnosed diabetes mellitus, the 3rd tertile of the acute-to-chronic glycemic ratio was linked with a worse COVID-19 outcome compared with the 1st tertile (odds ratio 3.33, 95% confidence interval 1.43-7.77), whereas glycated hemoglobin levels were not; among patients with pre-existing diabetes mellitus, glycated hemoglobin levels were linked with a worse outcome.

conclusionsAmong patients with undiagnosed diabetes mellitus with COVID-19, the magnitude of elevation of blood glucose from chronic to acute levels is associated with worse outcomes.

Indexed as

COVID-19Diabetes MellitusBlood GlucoseCohort StudiesGlycated HemoglobinHumansRetrospective StudiesBlood GlucoseGlycated HemoglobinAcute-to-chronic glycemic ratioCOVID-19Undiagnosed diabetes mellitus

Identifiers

PMID36708095
PMCPMC10034955
OpenAlexW4318391960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.